Smiths Medical, a leading global medical device manufacturer, announced today it has received FDA 510(k) clearance to market its CADD-Solis pain management system version 3.0 with Programmed Intermittent Bolus and Patient Controlled Analgesics delivery in the United States. The new customizable,...
Smiths Medical gets FDA clearance to market CADD-Solis system with PIB and PCA delivery in the US
Thursday, January 2, 2014
Smiths Medical gets FDA clearance to market CADD-Solis system with PIB and PCA delivery in the US
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment